Skip to content
- Vaccination against COVID-19 for children aged 5 to 11 The Lancet
- Effectiveness of the BNT162b2 vaccine against Omicron in children aged 5 to 11 years NEJM nejm.org
- The pediatric COVID vaccine is only 51% effective at Omicron, according to the Ynetnews study
- Efficacy of Pfizer-BioNTech BNT162b2 vaccine against Delta and Omicron SARS-CoV-2 variants among adolescents News-Medical.Net
- Vax’s “moderate” protection against Omicron for Medpage toddlers today
- See full coverage on Google News